Lucid Diagnostics Inc (LUCD) Provides Business Update, Reports Prelim Q4
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/1/2026
- Wall Street ends higher as Amazon soothes AI jitters
- Amazon shares rally as cloud growth surges and spending outlook climbs
- Apple shares sink on disappointing September quarter sales outlook
- Novo Nordisk stock tumbles 10% as key trial misses goal
- AI wizkid Leopold Aschenbrenner forced to sell entire portfolio after rout
- SCYNEXIS (SCYX) Move Attributed to Morning Note from Brookline
- AbbVie (ABBV) Misses Q2 EPS by 6c, Beats on Revenue; Offers FY26 EPS Guidance
- Short sellers pile into SpaceX ahead of earnings, lockup expiration
- Wall Street ends higher as Amazon soothes AI jitters
- Novo Nordisk's ziltivekimab fails to reduce heart risk in ZEUS trial
- After-Hours Stock Movers: AAPL, AMZN, COIN, RBLX, RDDT, AXTI, FND, WU, GDDY
- After-Hours Stock Movers: META, MSFT, CMG, SBUX, CVNA, LRCX, FTNT, QCOM, TDOC
- After-Hours Stock Movers: F, BE, STX, WDC, KLAC, SWKS, NXPI, CSGP, ENPH
- After-Hours Stock Movers: FFIV, CDNS, APLD, RMBS, ESI, SANM
- After-Hours Stock Movers: INTC, AMD, ARM, MXL, EW, DECK
Lucid Diagnostics Inc (LUCD) PT Lowered to $12 at Canaccord Genuity
March 29, 2022 7:40 AM EDTCanaccord Genuity analyst Kyle Mikson lowered the price target on Lucid Diagnostics Inc (NASDAQ: LUCD) to $12.00 (from $18.00) while maintaining a Buy rating.
... MoreLucid Diagnostics Inc (LUCD) PT Lowered to $7 at Needham & Company
March 29, 2022 6:31 AM EDTNeedham & Company analyst Mike Matson lowered the price target on Lucid Diagnostics Inc (NASDAQ: LUCD) to $7.00 (from $13.00) while maintaining a Buy rating after the company missed fourth-quarter revenue consensus.
The analyst commented, "LUCD missed consensus revenue in 4Q21. EsoGuard test volume grew 49% sequentially... More
